Matthew Gombrich, M.D., M.S.

CEO & Founder

Matthew Gombrich, M.D., M.S. has over 25 years of experience in the In-Vitro diagnostic sector spanning product, clinical and regulatory development. Matt was instrumental in clinical and market development of several rapid diagnostic assays for pneumonia-related pathogens, including the Binax (Alere) Rapid Legionella Assay and Pneumococcal Urinary Antigen tests. This included post-market clinical study design and the creation of sales and marketing educational content. More recently Matt led the development efforts of a rapid UTI assay that forms the core of Renascent Diagnostics. This included the company’s regulatory strategy and FDA communications. Matt received his Medical Degree in 2005 and his Master’s degree in Experimental Pathology from Case Western Reserve University School of Medicine in Cleveland in 2001.